179 related articles for article (PubMed ID: 18952365)
1. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.
Umbehr M; Bachmann LM; Held U; Kessler TM; Sulser T; Weishaupt D; Kurhanewicz J; Steurer J
Eur Urol; 2009 Mar; 55(3):575-90. PubMed ID: 18952365
[TBL] [Abstract][Full Text] [Related]
2. Functional magnetic resonance imaging in prostate cancer.
Seitz M; Shukla-Dave A; Bjartell A; Touijer K; Sciarra A; Bastian PJ; Stief C; Hricak H; Graser A
Eur Urol; 2009 Apr; 55(4):801-14. PubMed ID: 19185981
[TBL] [Abstract][Full Text] [Related]
3. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.
Wu LM; Xu JR; Gu HY; Hua J; Zhu J; Chen J; Zhang W; Hu J
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):252-64. PubMed ID: 23313568
[TBL] [Abstract][Full Text] [Related]
4. The value of magnetic resonance imaging in the detection of prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels: a meta-analysis.
Zhang ZX; Yang J; Zhang CZ; Li KA; Quan QM; Wang XF; Wang H; Zhang GX
Acad Radiol; 2014 May; 21(5):578-89. PubMed ID: 24703470
[TBL] [Abstract][Full Text] [Related]
5. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study.
Amsellem-Ouazana D; Younes P; Conquy S; Peyromaure M; Flam T; Debré B; Zerbib M
Eur Urol; 2005 May; 47(5):582-6. PubMed ID: 15826747
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer.
Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Zhu J; Ye YQ; Hu J
Acad Radiol; 2012 Oct; 19(10):1215-24. PubMed ID: 22958718
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging and spectroscopic imaging of prostate cancer.
Coakley FV; Qayyum A; Kurhanewicz J
J Urol; 2003 Dec; 170(6 Pt 2):S69-75; discussion S75-6. PubMed ID: 14610414
[TBL] [Abstract][Full Text] [Related]
8. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy.
Yuen JS; Thng CH; Tan PH; Khin LW; Phee SJ; Xiao D; Lau WK; Ng WS; Cheng CW
J Urol; 2004 Apr; 171(4):1482-6. PubMed ID: 15017203
[TBL] [Abstract][Full Text] [Related]
9. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added Value.
Platzek I; Borkowetz A; Toma M; Brauer T; Meissner C; Dietel K; Wirth M; Laniado M
J Comput Assist Tomogr; 2015; 39(5):674-80. PubMed ID: 25938212
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
Eur Urol; 2018 Jan; 73(1):81-91. PubMed ID: 28412063
[TBL] [Abstract][Full Text] [Related]
12. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.
Hamoen EHJ; de Rooij M; Witjes JA; Barentsz JO; Rovers MM
Eur Urol; 2015 Jun; 67(6):1112-1121. PubMed ID: 25466942
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results.
Bhatia C; Phongkitkarun S; Booranapitaksonti D; Kochakarn W; Chaleumsanyakorn P
J Med Assoc Thai; 2007 Jul; 90(7):1391-9. PubMed ID: 17710982
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.
Costouros NG; Coakley FV; Westphalen AC; Qayyum A; Yeh BM; Joe BN; Kurhanewicz J
AJR Am J Roentgenol; 2007 Mar; 188(3):812-6. PubMed ID: 17312072
[TBL] [Abstract][Full Text] [Related]
15. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
[TBL] [Abstract][Full Text] [Related]
16. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging.
Casciani E; Gualdi GF
Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379
[TBL] [Abstract][Full Text] [Related]
18. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopy in prostate cancer: hope or hype?
Roach M; Kurhanewicz J; Carroll P
Oncology (Williston Park); 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. PubMed ID: 11758871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
